Coherus Oncology, Inc.
Clinical trials sponsored by Coherus Oncology, Inc., explained in plain language.
-
New hope for advanced liver cancer? trial tests adding a third drug to standard treatment
Disease control CompletedThis study tested whether adding a new drug called SRF388 to a standard two-drug treatment could better control advanced liver cancer. It involved about 134 adults with newly diagnosed, inoperable liver cancer who had not yet received treatment. The main goals were to see if the …
Phase: PHASE2 • Sponsor: Coherus Oncology, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New cancer drug enters first human trials for Tough-to-Treat tumors
Disease control CompletedThis was a first-in-human study to test the safety and early effectiveness of a new drug called CHS-388 for people with advanced solid tumors. The trial enrolled 145 adults with cancers like kidney, liver, and lung cancer that had progressed after standard treatments. Researchers…
Phase: PHASE1 • Sponsor: Coherus Oncology, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC